Javelin Pharmaceuticals Inc.

(Public, AMEX:JAV)

The follow article has been submitted to StocksHaven Investments by Nicholas DeCesare, a highly respected investor and journalist within the biopharma realm.

Take one look at a chart of Javelin Pharmaceuticals over the past six months and you will see a stock that has doubled in price but still sits only around $2.00 per share.  In fact, just two years ago, the stock was being recommended by analysts with its stock price hovering around $7.00.  In short, as detailed on their website, Javelin is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and under-served medical need in the pain management market.  Javelin’s focus is different than other pharmaceutical companies’ pain management products: they develop new and proprietary administration routes for well-characterized molecules

...

Below are companies with market caps under $250 million from the BioMedReports.com FDA Calendar, which have either pending FDA decisions or pending clinical trial results that may have a major impact on each of the underlying stock prices. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in Extreme FDA and Clinical Trial Calendar Trades, which are highlighted in periodic articles at BioMedReports.com. Another approach is to simply buy such companies well ahead of their expected catalyst dates for a possible stock price increase as the date approaches and trading activity increases.

BioMimetic Therapeutics [BMTI: 9.07, -0.52 (-5.42%)]: On 6/17/09, BMTI announced that it has submitted both the pre-clinical pharmacology/toxicology and quality/manufacturing modules of its Premarket Approval (PMA) application for marketing of Augment Bone Graft

...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Aaron Rents Inc (RNT) Acxiom Corp (ACXM) Alliance One International Inc (AOI) Allied Capital Corp (ALD) American Equity Investment Life Holding (AEL) Anaren Inc (ANEN) Aqua America Inc (WTR) AsiaInfo Holdings Inc (ASIA) Broadridge Financial Solutions Inc (BR) Caribou Coffee Company Inc (CBOU) Carrols Restaurant Group Inc (TAST) Celldex Therapeutics Inc (CLDX) Chinacast Education Corp (CAST) Cosan Ltd (CZZ) DaVita Inc (DVA) Energy Recovery Inc (ERII) EZCORP Inc (EZPW) FPIC Insurance Group Inc (FPIC) General Mills Inc (GIS) Horsehead Holding Corp (ZINC) Immucor Inc (BLUD) Jarden Corp (JAH) Javelin Pharmaceuticals Inc (JAV) Magyar Telekom Plc (MTA) MAP Pharmaceuticals Inc (MAPP) Maxcom Telecomunic SAB de CV (MXT) Mercer Insurance Group ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Access National Corp (ANCX) Actuate Corp (ACTU) Alliance One International Inc (AOI) Allos Therapeutics Inc (ALTH) Amerisafe Inc (AMSF) Amtrust Financial Services Inc (AFSI) Anaren Inc (ANEN) AutoZone Inc (AZO) Baxter International Inc (BAX) Blackrock Kelso Capital Corp (BKCC) Briggs & Stratton Corp (BGG) Calumet Specialty Products Partners LP (CLMT) Chinacast Education Corp (CAST) Cyberonics Inc (CYBX) DCT Industrial Trust Inc (DCT) EZCORP Inc (EZPW) Fidelity National Financial Inc (FNF) Grupo Financiero Galicia SA (GGAL) HMS Holdings Corp (HMSY) Hormel Foods Corp (HRL) J&J Snack Foods Corp (JJSF) Javelin Pharmaceuticals Inc (JAV) Kindred Healthcare Inc (KND) Lundin Mining Corp (LMC) Magyar Telekom Plc (MTA) Medivation Inc (MDVN) Monro Muffler ...

Here are the stocks added to the Zacks #1 Rank (”strong buy”) List today:

Anglo Platinum Ltd (AGPPY)
Citi Trends Inc (CTRN)
CNS Response Inc (CNSO)
The Cooper Companies Inc (COO)
DCT Industrial Trust Inc (DCT)
Dynamics Research Corp (DRCO)
Emergent BioSolutions Inc (EBS)
Family Dollar Stores Inc (FDO)
FARO Technologies Inc (FARO)
Flanders Corp (FLDR)
Gammon Gold Inc (GRS)
Inverness Medical Innovations Inc (IMA)
ISTA Pharmaceuticals Inc (ISTA)
Javelin Pharmaceuticals Inc (JAV)
La Jolla Pharmaceutical Co (LJPC)
Majesco Entertainment Co (COOL)
Medivation Inc (MDVN)
Meruelo Maddux Properties Inc (MMPI)
Novavax Inc (NVAX)
NxStage Medical Inc (NXTM)
Oracle Corp (ORCL)
Rollins Inc (ROL)
Smith & Wesson Holding Corp (SWHC)
Symyx Technologies Inc (SMMX)
Thomson Reuters Corp (TRI)
TreeHouse Foods Inc (THS)
Tucows Inc …

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Acxiom Corp (ACXM) Koninklijke Ahold NV (AHONY) Allos Therapeutics Inc (ALTH) American Italian Pasta Co (AIPC) AsiaInfo Holdings Inc (ASIA) Broadridge Financial Solutions Inc (BR) CNS Response Inc (CNSO) Cosan Ltd (CZZ) Cray Inc (CRAY) CTI Industries Corp (CTIB) Cytokinetics Inc (CYTK) DTS Inc (DTSI) Enbridge Inc (ENB) Expedia Inc (EXPE) EZCORP Inc (EZPW) Flanders Corp (FLDR) Gamco Investors Inc (GBL) Inverness Medical Innovations Inc (IMA) INX Inc (INXI) Javelin Pharmaceuticals Inc (JAV) Majesco Entertainment Co (COOL) MAP Pharmaceuticals Inc (MAPP) Maxwell Technologies Inc (MXWL) Metavante Technologies Inc (MV) Monro Muffler Brake Inc (MNRO) Myriad Genetics Inc (MYGN) Onstream Media Corp (ONSM) PetMed Express Inc (PETS) Poniard ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

AEterna Zentaris Inc. (AEZS) Alleghany Corp. (Y) Amerisafe Inc. (AMSF) AXA (AXA) Banco Bilbao Vizcaya Argentaria SA (BBV) Bio-Imaging Technologies Inc. (BITI) Capitol Federal Financial (CFFN) Cardiome Pharma Corp. (CRME) CBIZ Inc. (CBZ) Cincinnati Bell Inc. (CBB) Conn's Inc. (CONN) Dean Foods Co. (DF) Denison Mines Corp. (DNN) Flanders Corp. (FLDR) GeoEye Inc. (GEOY) HMS Holdings Corp. (HMSY) Innovative Solutions & Support Inc. (ISSC) Inverness Medical Innovations Inc. (IMA) Investors Bancorp Inc. (ISBC) IPC The Hospitalist Co. Inc. (IPCM) Javelin Pharmaceuticals Inc. (JAV) Jos. A. Bank Clothiers Inc. (JOSB) Kaman Corp. (KAMN) Kao Corp. (KCRPY) La Jolla Pharmaceutical Co. (LJPC) Lancaster Colony Corp. (LANC) Life Partners Holdings Inc. (...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Koninklijke Ahold NV (AHONY) Bio-Imaging Technologies Inc (BITI) CBIZ Inc (CBZ) Command Security Corp (MOC) Continucare Corp (CNU) Daimler AG (DAI) DXP Enterprises Inc (DXPE) Flanders Corp (FLDR) Foster's Group Ltd (FBRWY) Human Genome Sciences (HGSI) Huron Consulting Group (HURN) I-Many Inc (IMNY) James Hardie Industries NV (JHX) Javelin Pharmaceuticals Inc (JAV) Jazz Pharmaceuticals Inc (JAZZ) La Jolla Pharmaceutical Co (LJPC) Life Partners Holdings Inc (LPHI) Lincoln Educational Services Corp (LINC) Metabasis Therapeutics Inc (MBRX) Northern Dynasty Minerals Ltd (NAK) Novavax Inc (NVAX) O'Reilly Automotive Inc (ORLY) Obagi Medical Products Inc (OMPI) Radiant Logistics Inc (RLGT) Ralcorp Holdings Inc (RAH) Reed Elsevier plc (RUK) Republic Services Inc (RSG) ...

Javelin Pharmaceuticals, Inc. announced today that it has signed an exclusive European marketing partnership for Dyloject(R) (diclofenac sodium for injection) with Therabel Pharma N.V. (”Therabel”). The contract could be worth up to $71 million in upfront, sales, and regulatory milestone payments plus a double digit royalty on future sales.

“Partnering Dyloject in Europe bolsters our financial resources and extends our cash until 2010 before achieving future milestones and potential additional product partnerships. We are retaining significant upside in Dyloject’s future EU growth with a high quality marketing partner while eliminating our European commercialization expenses,” stated Martin Driscoll, Javelin’s CEO.

He continued, “We are excited to be partnering with Therabel, with their demonstrated market success in hospital sales and pain management products in the EU. We believe Therabel will accelerate market uptake for Dyloject in the U.K. and will assure future growth as Therabel introduces the product in key countries throughout

...